The MSCI EMU Small Cap is an equity index representative of the most liquid stocks in the Euro zone having a capitalization of between $200 million and $1.5 billion USD. The index presented a bullish dynamic materialized by a ...
Day By Day – Indipendent Research
Sign up for our weekly Newsletter and receive the latest ETF and ETC news.
succession of troughs and peaks which were higher and higher and supported by the 100-day moving average. However, the deep bearish correction initiated in the month of May as well as the bearish reversal of the moving average incites us to be cautious as to the configuration of the index. We are therefore neutral in the medium-term, not anticipating new peaks in the weeks to come….
|2 months Opinion||NEUTRAL|
|2 weeks Opinion||POSITIVE|
|Resistances||168 / 176,48 pts|
|Supports||159,1 / 151,93 pts|
We are positive in the short-term and envision joining the resistance at 176.48 points, with an intermediary target of 168 points. We place the invalidation threshold of this positive opinion slightly below the major support at 159.10 points.
|Traker’s Name||Leverage||Expense ratio|
|AMUNDI ETF EURO STOXX SMALL CAP||x1||0,30%|
|CS ETF (IE) on MSCI EMU Small Cap||x1||0,58%|
|iShares DJ EuroSTOXX SmallCap||x1||0,40%|
|iShares STOXX Europe all 200 (DE)||x1||0,21%|
|Lyxor ETF MSCI EMU Small||x1||0,40%|
|SPDR MSCI Europe Small Cap ETF||x1||0,40%|
Follow-up Analysys: Our DBD Tracker dated 27/06/2011 recommended the purchase of the STOXX Europe 600 Health Care index. Since then our final target of 411.17 points was attained and overflowed, or a performance of 3.7%.
* A leverage of 1 means that the ETF/Tracker has the same performance as the underlying index. A leverage of 2 indicates that the ETF/Tracker will have twice the performance of the underlying index. A leverage of -1 indicates that the ETF/Tracker will perform opposite that of the index: it will rise while the index falls, and vice versa.
This publication is solely intended as information and does not constitute any investment advice or an offer, solicitation or recommendation to acquire or dispose of any investment or to engage in any transaction. Althoughthis publicationis issued in good faith, no representation or warranty, express or implied, is or willbe made and no responsibility or liability is or willbe accepted by NYSE Euronext or by any of its officers, employees or agents in relation to the accuracy or completeness of this publicationand any such liability is expressly disclaimed.No information set out or referred to in this publicationshall form the basis of any contract. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by NYSE Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. NYSE Euronext encourages you to reach your own opinion as to whether investments are appropriate or relevant and recommends you not to make any decisions on the basis of the information contained in this publication before checking it, as you will bear full responsibility for any use that you make of it. Persons wishingto trade products available on NYSE Euronextmarkets or wishingto offer such products to third parties are advised, before doing so, to check their legal and regulatory position in the relevant territory and to understand the related risks. All proprietary rights and interest in or connected with this publicationare vested in NYSE Euronext.No part of it may be redistributed or reproduced in any form or by any means or used to make any derivative work (such as translation, transformation, or adaptation) without the prior written permission of NYSE Euronext. NYSE Euronext refers to NYSE Euronext and its affiliates and references to NYSE Euronext in this publication include each and any such company as the context dictates. NYSE EuronextSM, Euronext®, trackers®, are registered marks of NYSE Euronext.
Source: ETFWorld – Day By Day – Indipendent Research